Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET. (Q38850382)

7 September 2017

Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET. (English)

1 reference

7 September 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Tony Frugier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Catriona A. McLean

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Colin L. Masters

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

Monica Lind

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Aaron Z Wagen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Alan Rembach

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Qiao-Xin Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Timothy M Ryan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

James D Doecke

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Christopher C Rowe

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Victor L Villemagne

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

5 March 2017

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1486-1498

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

4 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Analysis of a compartmental model of amyloid beta production, irreversible loss and exchange in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Isolation of intracellular membranes by means of sodium carbonate treatment: application to endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Binding of the Alzheimer amyloid beta-peptide to neuronal cell membranes by fluorescence correlation spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Mechanism of neuronal versus endothelial cell uptake of Alzheimer's disease amyloid beta protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Decreased clearance of CNS beta-amyloid in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Overlapping profiles of Aβ peptides in the Alzheimer's disease and pathological aging brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Age and amyloid effects on human central nervous system amyloid-beta kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

The effect of oxysterols on the interaction of Alzheimer's amyloid beta with model membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

The role of metallobiology and amyloid-β peptides in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Amyloid imaging with PET in early Alzheimer disease diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Alzheimer's disease and the amyloid β-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Biphasic microreactor for efficient membrane protein pretreatment with a combination of formic acid assisted solubilization, on-column pH adjustment, reduction, alkylation, and tryptic digestion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

Electrophoretic Separation of βA4 Peptides (1–40) and (1–42)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWX057

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWX057

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28383676%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference